Jump to main content
Topic: Specialty Drugs
-
Mortgaging New Treatments Kicks the Can on High Drug Prices
Read More
-
A $475,000 price tag for a new cancer drug: crazy or meh?
Read More
-
Prevalence of Off-Label Use and Spending Among Patent-Protected Chemotherapies
Read More
-
Abandon Biosimilars as Biologics are Natural Monopolies
Read More
-
Overview of Original Subscription Model and Features of LA and WA Proposals
Read More
-
The “Netflix Model” of Financing Hepatitis C Treatment
Read More
-
Perspective on National Coverage Analysis of CAR-T Therapies
Read More
-
R&D Costs Do Not Explain Elevated U.S. Drug Prices
Read More
-
The U.S. Government Should Buy Gilead for $156Bn to Save Money on Hep C
Read More
-
Hospital Outpatient versus Doctor Office Cost for Physician Administered Cancer Drugs
Read More